Core Laboratories (CLB) Deferred Taxes (2022 - 2026)

Core Laboratories' Deferred Taxes history runs 5 years deep, the most recent figure standing at $3.7 million for Q1 2026.

• On a quarterly basis, Deferred Taxes rose 104.68% year-over-year to $3.7 million in Q1 2026; TTM through Mar 2026 was $482000.0, a 87.86% decrease from a year earlier, with the FY2025 full-year figure at -$1.4 million, down 110.68% from the prior year.
• Deferred Taxes climbed to $3.7 million in Q1 2026 per CLB's latest filing, from -$6.0 million in the prior quarter.
• Across five years, Deferred Taxes topped out at $11.9 million in Q2 2023 and bottomed at -$6.0 million in Q4 2025.
• The 5-year median for Deferred Taxes is $1.3 million (2025), against an average of $835533.3.
• Biggest YoY gain for Deferred Taxes was 259.95% in 2025; the steepest drop was 947.73% in 2025.
• Year by year, Deferred Taxes stood at -$2.2 million in 2022, then slumped by 76.16% to -$3.9 million in 2023, then jumped by 85.5% to -$572000.0 in 2024, then slumped by 947.73% to -$6.0 million in 2025, then jumped by 162.06% to $3.7 million in 2026.
• Per Business Quant, the three latest CLB Deferred Taxes figures stand at $3.7 million (Q1 2026), -$6.0 million (Q4 2025), and $1.4 million (Q3 2025).